GBI

Founded in Shanghai in 2002, GBI has built a diverse portfolio of market intelligence solutions for pharmaceutical and device companies and other service providers. Focused on China and the Latin American markets, GBIs value-added industry information, news, and data services power individuals and organizations decision-making and enable more effective communication. As a trusted source of information, GBI has established long-term relationships with both multinational players and local firms, and continues to drive forward the health care industry. GBI has offices in Shanghai, Beijing, and Washington D.C

China,brazil,healthcare,health 2.0,pharmaceuticals,business intelligence,data,big data,medical devices,consulting,market entry,salesforce targeting,mobile applications,healthcare policy,drug reimbursement,drug pricing,sfda,kol mapping,physician engagement,patient engagement,and latin america

Gbi operates in the Information services industry.

Gbi's revenue is 11m - 100m

Gbi has 201 - 500 employees.